FDA Approves First Once-Daily Oral Plaque Psoriasis Drug
Verywell Health,
Key Takeaways Regulators approved an oral once-daily drug, called Sotyktu (ducravacitinib) for treating moderate to severe…
Key Takeaways Regulators approved an oral once-daily drug, called Sotyktu (ducravacitinib) for treating moderate to severe…
Share on PinterestA new drug for plaque psoriasis has been approved by U.S. regulators.
Recently, the Food and Drug Administration (FDA) has approved Rinvoq for some people with atopic dermatitis.